Vertex to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13

Rhea-AI Summary

Vertex Pharmaceuticals (NASDAQ: VRTX) has announced that its CEO and President, Dr. Reshma Kewalramani, will deliver a presentation at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025, at 10:30 a.m. ET/7:30 a.m. PT.

The presentation will be accessible through a live webcast on the company's website (www.vrtx.com) under the 'Investors' section's 'News and Events' page. A replay of the conference webcast will be made available in the company's website archive.

BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Dr. Reshma Kewalramani, Chief Executive Officer and President, will present at the 43^rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 10:30 a.m. ET/7:30 a.m. PT.

A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website.

About Vertex

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, primary membranous nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes and myotonic dystrophy type 1.

Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia, Latin America and the Middle East. Vertex is consistently recognized as one of the industry's top places to work, including 15 consecutive years on Science magazine's Top Employers list and one of Fortune’s 100 Best Companies to Work For. For company updates and to learn more about Vertex's history of innovation, visit www.vrtx.com or follow us on LinkedIn, Facebook, Instagram, YouTube and X.

(VRTX-WEB)

View source version on businesswire.com: https://www.businesswire.com/news/home/20241223635085/en/

Vertex Pharmaceuticals Incorporated

Investors:

InvestorInfo@vrtx.com

Source: Vertex Pharmaceuticals Incorporated

FAQ

When is Vertex Pharmaceuticals (VRTX) presenting at the J.P. Morgan Healthcare Conference 2025?

Vertex Pharmaceuticals will present at the conference on Monday, January 13, 2025, at 10:30 a.m. ET/7:30 a.m. PT.

How can investors watch Vertex's (VRTX) J.P. Morgan Healthcare Conference presentation?

Investors can watch the presentation through a live webcast available on Vertex's website (www.vrtx.com) in the 'Investors' section under 'News and Events'.

Will Vertex's (VRTX) J.P. Morgan Healthcare Conference presentation be available for replay?

Yes, a replay of the conference webcast will be archived on Vertex's company website.

Who will represent Vertex Pharmaceuticals (VRTX) at the 2025 J.P. Morgan Healthcare Conference?

Dr. Reshma Kewalramani, Chief Executive Officer and President of Vertex Pharmaceuticals, will present at the conference.